Navigation Links
Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes
Date:5/22/2009

offer to sell nor a solicitation to buy any of these securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota.

Cephalon has a growing presence in Europe, the Middle East and Africa. The Cephalon European headquarters and pre-clinical development center are located in Maisons-Alfort, France, just outside of Paris. Key business units are located in England, Ireland, France, Germany, Italy, Spain, the Netherlands for the Benelux countries, and Poland for Eastern and Central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology.

The company's proprietary products in the United States include: TREANDA(R) (bendamustine hydrochloride) for Injection, AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), FENTORA(R) (fentanyl buccal tablet) [C-II], PROVIGIL(R) (modafinil) Tablets [C-IV], TRISENOX(R) (arsenic trioxide) injection, GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(R) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on U.S. products is available by calling 1-800-896-5855.

In addition to historical fa
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... parents that buying an older car for their teens may put ... killed in the United States between 2008 and 2012 were driving ... important safety features that are available on newer cars, the study ... in cars at least six years old, 34 percent were in ... 11 to 15 years old, and 17 percent were in cars ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Injectable drug ... double the suicide attempt rate of other substance users, ... use is associated with the risk of suicide attempt ... the University of Montreal, said in a university news ... users. We wanted to know who among substance users ...
(Date:12/19/2014)... Surviving Mesothelioma says thousands of water pipes in the ... can leach asbestos into drinking water as they age. ... the Surviving Mesothelioma website. , According to the EPA, ... water mains made of asbestos cement are the major source ... consumers from mesothelioma , water providers are subject to routine ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 B. E. ... to healthcare providers, has been retained to lead a ... Memorial Hospital in Franklin, Ind. The top executive search ... recently placed more than 900 healthcare executives into organizations. ... full service hospital providing care to the residents of ...
(Date:12/19/2014)... December 19, 2014 Pain Free Living ... excited to announce a new Superior magnetic necklace ... These are the strongest neodymium magnets for the fastest ... Living developed the Superior Magnetics brand for the fastest ... Living performs magnetic therapy using Superior Magnetic Jewelry at ...
Breaking Medicine News(10 mins):Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2
... Germany have offered an endoscopic examination of the colon ... the age of 55. Germany was the first country ... part of its statutory early cancer detection program. ... DKFZ have now published a first calculation of the ...
... -EXTON, Pa., March 23 Therakos, Inc., a ... U.S. Food and Drug Administration (FDA) approval of ... (reducing the severity of symptoms) treatment of the ... that are unresponsive to other forms of treatment. ...
... by limiting meds in those with risk factor , , ... variants associated with a risk factor for sudden cardiac ... data from more than 13,000 people. , The gene ... electrocardiograms (EKGs) routinely used by doctors to assess patients, ...
... Inc. (OTC Bulletin Board: TCSR) (the "Company"), a developer, manager ... appointment of Kirk B. Shulke, M.D. to the Company,s Board ... to TrinityCare for over three years and has extensive experience ... is a graduate of the University of Texas ...
... You went on a diet. Great. You lost weight. ... off? What are your chances of avoiding the notorious Yo-Yo ... that you turn to your doctor and ask for a ... of your IgG antibodies against two prevalent viruses, EBV (Epstein-Barr ...
... Risk Management Applications to Extend Oracle,s Leadership in Health SciencesREDWOOD ... , , ... acquire Relsys International, Inc. ("Relsys"), a leading provider of drug ... health sciences industry. , ...
Cached Medicine News:Health News:Germany: Colonoscopy prevents 15,000 cancer cases 2Health News:U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System 2Health News:U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System 3Health News:Study IDs Gene Variants Tied to Sudden Cardiac Death 2Health News:TrinityCare Appoints Kirk B. Shulke, M.D. to Board of Directors 2Health News:How to Keep the Weight Off? By Taking Gene-Eden, a New Dietary Supplement Based on Dr. Hanan Polansky's Discovery of the Cause of Many Diseases 2Health News:Oracle Buys Relsys 2Health News:Oracle Buys Relsys 3
(Date:12/19/2014)... -- In the Friday, December 19 edition of USA ... Technology (HIT) features Konica Minolta, the company announced today. The supplement ... leading healthcare organizations. In addition to the print ... as New York , Chicago ... Minneapolis and San Francisco ...
(Date:12/19/2014)... 19, 2014 TODAY, AEGATE, the ... World announced the appointment of Peter Fox ... Chief Channels and Partner Officer. Peter has ... to its acquisition by Oracle in 2011. ... Geneva and subsequently Convergys, a world ...
(Date:12/19/2014)... , Dec. 19, 2014  Newport Corporation (NASDAQ: ... Kadia, Ph.D. has joined the company,s Board of ... Officer and a director of Evans Analytical Group, ... evaluation and analytical services to companies in a ... to joining Evans Analytical Group, Dr. Kadia spent ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... Amarin Corporation plc (Nasdaq: AMRN ) ... on cardiovascular disease, today announced that, in connection with ... Shares ("ADSs"), the underwriters of the offering have exercised ... aggregate of 1,800,000 additional ADSs to cover over-allotments.  The ...
... 7, 2011 Echo Therapeutics, Inc. (OTC Bulletin Board: ... Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous ... transdermal drug delivery, today announced that Patrick T. Mooney, ... Echo Therapeutics will present at the OneMedForum 2011 annual ...
Cached Medicine Technology:Amarin Announces Underwriters' Exercise of Over-Allotment Option 2Amarin Announces Underwriters' Exercise of Over-Allotment Option 3Amarin Announces Underwriters' Exercise of Over-Allotment Option 4Echo Therapeutics to Present at the OneMedForum 2011 Conference 2
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Lyphochek Anemia Control provides low/deficient values for many analytes specific to anemia, as well as very low TSH values for ultrasensitive TSH testing....
... Lyphochek Fertility Control ... monitor the clinically significant ... most frequently assayed during ... Elevated hCG and hCG-Beta ...
Lyphochek Hypertension Markers Control is a trilevel control designed to monitor the performance of testing procedures for renin and other analytes associated with hypertension disorders....
Medicine Products: